Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2019
Cash flows from operating activities:
Net income	$ 660,870	$ 221,384	$ 132,465
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	113,398	98,933	73,139
Amortization of intangibles	117,183	97,234	75,638
Amortization of debt issuance costs	15,407	10,743	6,189
Impairment charges	0	10,057	0
Foreign currency forward contract loss	0	0	70,777
Deferred income tax benefit	(9,026)	(11,212)	(9,059)
Loss on disposition of property, plant and equipment	1,136	3,990	739
Stock-based compensation expense	30,514	19,889	18,950
Changes in assets and liabilities:
Accounts receivable	(234,693)	(115,232)	136,145
Inventories	(538,756)	133,290	283,311
Prepaid income taxes, expenses and other	(32,717)	18,427	(13,114)
Accounts payable	229,173	60,469	(120,507)
Guarantee liabilities related to former EHG subsidiaries	0	0	(108,843)
Accrued liabilities and other	123,078	(14,059)	(46,612)
Long-term liabilities and other	50,915	7,028	8,801
Net cash provided by operating activities	526,482	540,941	508,019
Cash flows from investing activities:
Purchases of property, plant and equipment	(128,835)	(106,697)	(130,224)
Proceeds from dispositions of property, plant and equipment	1,950	27,677	2,732
Business acquisitions, net of cash acquired	(310,938)	0	(1,658,577)
Foreign currency forward contract payment related to business acquisition	0	0	(70,777)
Equity investment in joint venture	0	0	(6,500)
Other	9,330	(5,229)	(2,157)
Net cash used in investing activities	(428,493)	(84,249)	(1,865,503)
Cash flows from financing activities:
Borrowings on term-loan credit facilities	0	0	2,095,018
Borrowings on revolving asset-based credit facilities	225,676	379,222	100,000
Payments on term-loan credit facilities	(59,700)	(274,963)	(242,919)
Payments on revolving credit facilities	(224,836)	(379,986)	(100,000)
Payments on unsecured notes	0	0	(84,728)
Payments on other debt	(13,950)	(14,493)	(70,319)
Payments of debt issuance costs	0	0	(70,176)
Cash dividends paid	(90,801)	(88,318)	(84,139)
Payments on finance lease obligations	(749)	(442)	(405)
Payments related to vesting of stock-based awards	(8,317)	(3,763)	(4,418)
Other	(15,761)	(10,173)	1,159
Net cash provided by (used in) financing activities	(188,438)	(392,916)	1,539,073
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(2,208)	26,325	(5,576)
Net increase (decrease) in cash and cash equivalents and restricted cash	(92,657)	90,101	176,013
Cash and cash equivalents and restricted cash, beginning of period	541,363	451,262	275,249
Cash and cash equivalents and restricted cash, end of period	448,706	541,363	451,262
Less: restricted cash	2,854	2,844	25,647
Cash and cash equivalents, end of period	445,852	538,519	425,615
Supplemental cash flow information:
Income taxes paid	226,527	56,803	87,813
Interest paid	78,865	101,784	57,189
Non-cash investing and financing transactions:
Capital expenditures in accounts payable	6,304	3,458	4,332
Common stock issued for business acquisition	$ 0	$ 0	$ 144,168